wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33422543-4C74AC23-76B8-44DC-9BB3-4FA2ED6F883C
Q33422543-4C74AC23-76B8-44DC-9BB3-4FA2ED6F883C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-4C74AC23-76B8-44DC-9BB3-4FA2ED6F883C
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies
P2860
Q33422543-4C74AC23-76B8-44DC-9BB3-4FA2ED6F883C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422543-4C74AC23-76B8-44DC-9BB3-4FA2ED6F883C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b6d495113d0a9d689a6cb524f1a8cce949c05aa0
P2860
Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.